1.49
2.61%
-0.04
시간 외 거래:
1.47
-0.02
-1.34%
전일 마감가:
$1.53
열려 있는:
$1.51
하루 거래량:
83,988
Relative Volume:
0.61
시가총액:
$57.16M
수익:
$135.87M
순이익/손실:
$72.20M
주가수익비율:
1.7738
EPS:
0.84
순현금흐름:
$45.09M
1주 성능:
+0.68%
1개월 성능:
+2.05%
6개월 성능:
+1.36%
1년 성능:
-34.65%
Scynexis Inc Stock (SCYX) Company Profile
명칭
Scynexis Inc
전화
201-884-5485
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-01-22 | 개시 | Guggenheim | Buy |
2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
2018-07-11 | 업그레이드 | Needham | Hold → Buy |
2018-06-27 | 개시 | Maxim Group | Buy |
2017-10-24 | 개시 | Guggenheim | Buy |
2017-07-10 | 개시 | ROTH Capital | Buy |
2017-05-09 | 다운그레이드 | Needham | Buy → Hold |
2017-03-03 | 재확인 | RBC Capital Mkts | Outperform |
2016-10-20 | 개시 | H.C. Wainwright | Buy |
2016-10-07 | 업그레이드 | WBB Securities | Buy → Strong Buy |
2016-10-03 | 재개 | Brean Capital | Buy |
2016-08-17 | 개시 | Guggenheim | Buy |
2016-08-09 | 재확인 | Needham | Buy |
2016-08-09 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
2016-03-28 | 개시 | Brean Capital | Buy |
2015-12-29 | 개시 | WBB Securities | Speculative Buy |
2015-11-16 | 재확인 | RBC Capital Mkts | Outperform |
2015-06-10 | 개시 | Needham | Buy |
2014-05-29 | 개시 | Canaccord Genuity | Buy |
2014-05-29 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Scynexis Inc 주식(SCYX)의 최신 뉴스
SCYNEXIS (NASDAQ:SCYX) Shares Pass Below 200 Day Moving Average of $1.82 - MarketBeat
CRISPR Therapeutics: Prepare To Be Bored (NASDAQ:CRSP) - Seeking Alpha
Potential Price Increase for Synopsys, Inc. (SNPS) After Recent Insider Activity - Knox Daily
Scynexis CEO acquires $27,400 in company stock By Investing.com - Investing.com Canada
Syncona Advances Share Buyback, Bolsters Treasury Shares - TipRanks
Xero buys South African firm for $115m in 'departure' - New Zealand Herald
SCYNEXIS, Inc. (NASDAQ:SCYX) CEO Gonzalez David Angulo Buys 20,000 Shares - MarketBeat
Scynexis CEO acquires $27,400 in company stock - Investing.com
Synectics says trading is 'significantly ahead' of previous guidance - Proactive Investors USA
Better than expected profits forecast for security tech company - The Business Desk
Synopsys Inc. stock rises Friday, still underperforms market - MarketWatch
SCYNEXIS (NASDAQ:SCYX) Stock Crosses Below 200-Day Moving Average of $1.83 - MarketBeat
SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook - TipRanks
SCYNEXIS (NASDAQ:SCYX) Shares Cross Below 200-Day Moving Average of $1.84 - MarketBeat
Financial Fitness Check: Examining Scynexis Inc (SCYX)’s Key Ratios - The Dwinnex
SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference - StockTitan
SCYNEXIS (NASDAQ:SCYX) Downgraded by StockNews.com to Sell - Defense World
SCYNEXIS (NASDAQ:SCYX) Downgraded to "Sell" at StockNews.com - MarketBeat
SCYNEXIS Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Scynexis: Q2 Earnings Snapshot - San Antonio Express-News
Scynexis: Q2 Earnings Snapshot - San Francisco Chronicle
Scynexis: Q2 Earnings Snapshot - Press of Atlantic City
SCYNEXIS Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt? - Simply Wall St
Acadian Asset Management LLC Purchases 21,700 Shares of SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World
SCYNEXIS secures $10 million milestone from GSK - Investing.com India
SCYNEXIS secures $10 million milestone from GSK By Investing.com - Investing.com Canada
SCYNEXIS secures $10 million milestone from GSK - Investing.com
SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports - StockTitan
3 Stocks Under $10 With the Potential for Massive Gains - InvestorPlace
Empowered Funds LLC Has $130,000 Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World
3 Dirt-Cheap Drug Developers With Blockbuster Potential - InvestorPlace
SCYNEXIS Reports First Quarter 2021 Financial Results and Provides Corporate Update - Quantisnow
A Look Into Healthcare Sector Value Stocks - Quantisnow
Trade Alert: The CEO, President & Director Of SCYNEXIS, Inc. (NASDAQ:SCYX), Marco Taglietti, Has Just Spent US ... - Yahoo Movies UK
SCYNEXIS (NASDAQ:SCYX) shareholders are up 14% this past week, but still in the red over the last five years - Yahoo New Zealand News
SCYNEXIS (NASDAQ:SCYX) Stock Price Passes Below Fifty Day Moving Average of $2.01 - Defense World
SCYNEXIS (NASDAQ:SCYX) Share Price Crosses Below Fifty Day Moving Average of $2.01 - MarketBeat
Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Lifestyle Singapore
SCYNEXIS Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders - Quantisnow
Ileal Sodium/Bile Acid Cotransporter Market 2030 | CJ HealthCare Corp, GlaxoSmithKline Plc, Scynexis Inc, Takeda ... - PrimePair
SCYNEXIS shareholders approve key proposals at annual meeting By Investing.com - Investing.com Australia
SCYNEXIS shareholders approve key proposals at annual meeting By Investing.com - Investing.com
Metric Analysis: Scynexis Inc (SCYX)'s Key Ratios in the Limelight – DWinneX - The Dwinnex
Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) 32% Price Drop - Simply Wall St
Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025 - Yahoo Finance
Decheng Capital LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - MarketBeat
Scynexis: 3Q Earnings Snapshot - Yahoo Movies UK
Ratio Revelations: Scynexis Inc (SCYX)'s Financial Metrics in the Spotlight – DWinneX - The Dwinnex
Scynexis Inc (SCYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):